-
Signature
-
/s/ Mark McKechnie, Attorney-in-Fact for Jian Wang
-
Issuer symbol
-
ACMR
-
Transactions as of
-
22 Aug 2025
-
Net transactions value
-
-$1,524,000
-
Form type
-
4
-
Filing time
-
26 Aug 2025, 16:30:25 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Wang Jian |
Chief Executive Officer and President of ACM Research (Shanghai), Inc., a subsidiary of the Issuer |
C/O ACM RESEARCH, INC., 42307 OSGOOD ROAD, SUITE I, FREMONT |
/s/ Mark McKechnie, Attorney-in-Fact for Jian Wang |
26 Aug 2025 |
0001721620 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACMR |
Class A Common Stock |
Options Exercise |
$168,000 |
+30,000 |
+12% |
$5.60 |
283,158 |
22 Aug 2025 |
Direct |
|
| transaction |
ACMR |
Class A Common Stock |
Sale |
$900,000 |
-30,000 |
-11% |
$30.00 |
253,158 |
22 Aug 2025 |
Direct |
F1 |
| transaction |
ACMR |
Class A Common Stock |
Options Exercise |
$168,000 |
+30,000 |
+12% |
$5.60 |
283,158 |
25 Aug 2025 |
Direct |
|
| transaction |
ACMR |
Class A Common Stock |
Sale |
$960,000 |
-30,000 |
-11% |
$32.00 |
253,158 |
25 Aug 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ACMR |
Stock Option |
Options Exercise |
$0 |
-30,000 |
-33% |
$0.000000 |
60,000 |
22 Aug 2025 |
Class A Common Stock |
30,000 |
$5.60 |
Direct |
F2 |
| transaction |
ACMR |
Stock Option |
Options Exercise |
$0 |
-30,000 |
-50% |
$0.000000 |
30,000 |
25 Aug 2025 |
Class A Common Stock |
30,000 |
$5.60 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
Remarks:
Chief Executive Officer and President of ACM Research (Shanghai), Inc., a subsidiary of the Issuer